|
Volumn 16, Issue 2, 2008, Pages 143-148
|
Intramyocardial angiogenic cell precursor injection for cardiomyopathy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADULT;
AGED;
ARTICLE;
BLOOD CELL;
CARDIOMYOPATHY;
CELL COUNT;
CLINICAL ARTICLE;
CLINICAL EFFECTIVENESS;
CLINICAL TRIAL;
CONGESTIVE CARDIOMYOPATHY;
FEMALE;
FUNCTIONAL ASSESSMENT;
HEART EJECTION FRACTION;
HUMAN;
ISCHEMIC CARDIOMYOPATHY;
MALE;
MYOCARDIAL DISEASE;
PATIENT SAFETY;
STEM CELL TRANSPLANTATION;
THORACOSCOPY;
TREATMENT RESPONSE;
ANGIOGENESIS;
CONVALESCENCE;
EQUIPMENT DESIGN;
FEASIBILITY STUDY;
HEART LEFT VENTRICLE FUNCTION;
HEART MUSCLE;
HEART MUSCLE ISCHEMIA;
HEART STROKE VOLUME;
HOSPITALIZATION;
INSTRUMENTATION;
INTRALESIONAL DRUG ADMINISTRATION;
METHODOLOGY;
MIDDLE AGED;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PATHOLOGY;
PATHOPHYSIOLOGY;
PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;
PILOT STUDY;
TIME;
TREATMENT OUTCOME;
ADULT;
AGED;
AGED, 80 AND OVER;
CARDIOMYOPATHIES;
CARDIOMYOPATHY, DILATED;
EQUIPMENT DESIGN;
FEASIBILITY STUDIES;
FEMALE;
HUMANS;
INJECTIONS, INTRALESIONAL;
MAGNETIC RESONANCE IMAGING;
MALE;
MIDDLE AGED;
MYOCARDIAL ISCHEMIA;
MYOCARDIUM;
NEOVASCULARIZATION, PHYSIOLOGIC;
PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;
PILOT PROJECTS;
RECOVERY OF FUNCTION;
SEVERITY OF ILLNESS INDEX;
STROKE VOLUME;
THORACOSCOPY;
TIME FACTORS;
TREATMENT OUTCOME;
VENTRICULAR FUNCTION, LEFT;
|
EID: 42949164585
PISSN: 02184923
EISSN: None
Source Type: Journal
DOI: 10.1177/021849230801600213 Document Type: Article |
Times cited : (14)
|
References (18)
|